Drug maker BioSyent Pharma has launched its new oral iron supplement, known as FeraMAX Powder, in Canada, which will also mark its international induction.
Commenting on the introduction, BioSyent president and CEO René Goehrum said that the launch of FeraMAX Powder further strengthens the company's position as a iron supplement solutions provider for healthcare professionals and their patients.
Like FeraMAX 150, the new medicine FeraMAX Powder is used for the prevention of iron deficiency and anaemia in newborns, infants, children and adults.
Available in a dissolvable powder and in grape/raspberry flavored gluten and alcohol-free crystals, the oral iron supplement can be easily taken by dissolving in water or mixing with soft foods.
Contrary to the conventional oral iron products for infants and children, the new medicine is also suitable for adult patients that have difficulty in swallowing pills.
Trading on the Toronto Venture Exchange, BioSyent is a growth oriented specialty pharma company which searches the globe to in-license or acquire pharmaceutical products that have been successfully developed, are safe and effective.
